RC Capital’s Post

Top 25 Healthcare Investors in 2024. What a list to be a part of! Rami El Assal gave me an opportunity to bring my skillset to bear in his due diligence team, and along the way built with managing partners Stephen Thaddeus Connelly and Ryan Spitler, Ph.D. a Top 25 venture fund. For anyone out there looking to expand their skill set, I encourage you to take that leap of faith and aggressively pursue those opportunities that will get you to where you want to achieve in your professional career. Boutique was a fit for me because: - They had great deal flow and brought creativity to deals that allowed great deals to get done where conventional thinking wouldn't work - Deep scientific expertise. I get to learn about cutting-edge technology on a diligence team that writes academic books on the topics they invest in. - Their long-term support with investments gives me a front-row seat to witness companies and their founders grow into professional entrepreneurs and successful businesses - The people of Boutique have the right kind of ego. They know what they know, cold. They learn what they need to learn. Their approach has created opportunities for me to work with other prestigious venture firms because they benefit from Boutique's domain and deal expertise without the attitude. So, definitely make your list. Knock on doors... and don't take no for an answer. Even without a Top 25 nomination, supporting Boutique has continued to be a world-class experience. Many thanks to Boutique for this opportunity and my co-conspirator Craig Rochester for the pearls of wisdom he drops on our due diligence calls. #intellectualproperty #venturecapital

This table contains the most active investors currently competing in kidney related health care innovation across their respective company lifecycle. The group broadly represents four investor types that provide this timeline to consider performance stage indicators starting from early initial idea implementation to accerated performance indicators, capital restructuring, credit acquisitions to a finalized IPO: (a) accelerators; (b) early stage venture capital; (c) growth equity; and (d) strategic capital. #unitedseniorassociation #usa #advocate #safeservicesolutions #recoveredreflections #healthcare #technology #ditigalhealth #CMS #kloekorby #nyclifestyleinfluencer #leadership #community #initiative #seniorcare #sustainable #united #innovation #development #HHS #humanity #eldercare #NYC #linkedinforcreators #patientcare

Today we are thrilled to announce that we have successfully raised €530m for our third-generation Growth platform, Ardian Growth III. With a team of 14 professionals headquartered in Paris and led by Alexis Saada alongside three Managing Directors, Romain Chiudini, Geoffroy de La Grandiere and Frédéric Quéru, our fund’s pan European investment strategy retains its focus on dynamic industries powered by innovative thinking such as digital (software, web and tech-enabled businesses), expert B2B services or health & wellness. In an otherwise challenging fundraising environment, we are proud to have exceeded our fundraising target, more than doubling the size in comparison with the previous vintage. The successful fundraising reflects strong interest from an increasingly diversified and international LP base, alongside a high re-up rate from existing investors. The fund received commitments from investors across 12 countries, including banks, insurance companies, entrepreneurs, pension funds and government agencies. Noticeably, over 120 of our LPs are entrepreneurs, highlighting the trust they place in our team to drive high-quality growth stories. The fund is already close to 25% invested, following three transactions in category leaders such as Théradial, a dialysis solutions provider; My Pie, an innovative snacking concept; and APRIUM PHARMACIE, a pharmacy banner company. We extend our heartfelt thanks to all our entrepreneurs and investors for their sustained trust and support. Read the announcement → https://bit.ly/3wSgILk #Growth #PrivateEquity #Digital #Europe Florian Dupont Pierre Schaeffer Romain Grellier Olivier Roy Alexandra Da Silva Léa Chaplain Solène Hamouda Niccolo Saligari Noa Amzallag Sophie Meyer

📆 Q2 is here! And with that come the announcements for 2023 Deal of the Year 🤝 🌟🎉 Huge congratulations to Warburg Pincus LLC on clinching the Deal of the Year for their $8.9 billion exit from Summit Health (formerly CITYMD)! 🚀💼 🔍 A quick dive into this deal by Iris Dorbian reveals the incredible journey of Summit Health - an urgent care powerhouse in the New York metro. The sale to VillageMD for a whopping $8.9 billion is nothing short of spectacular. 🏥💸 🌀 Caught in the whirlwind of the pandemic, Summit Health, a beacon of hope in NYC's covid testing scene, saw unprecedented challenges. "Everything was turned upside down in New York," recalls Warburg's TJ Carella. 🌆🦠 🤝 The strategic merger with CityMD in 2019, just before the pandemic hit, added layers of complexity to an already intricate narrative. For an insider's look into how Warburg navigated these waters, don't miss the full story. 🔗 👉 https://lnkd.in/dwxi2wPT 🏆 Also, a round of applause for the other victors: Kaiser Permanente for the $5 billion portfolio sale 🥈 Ares Management Corporation for the transformative exit of Savers | Value Village 🔄 BlackRock LTPC for the international sale of Creed, with a royal heritage 🌍 Vestar Capital Partners & Vesey Street Capital Partners for their wins in the Mid-Market and Small Market sectors respectively 🏅 #DealOfTheYear #PrivateEquity #PrivateEquityFirm #PrivateEquityFunds #VentureCapital #GrowthEquity #SummitHealth #WarburgPincus #MergersAndAcquisitions #HealthcareInvestment

💡 Interesting insight: Private equity firm Cressey & Company acquires long-term care services provider HealthDrive. 🔎 Insights: - Capital Double Impact was the seller 🤝 - Cressey & Company is a prominent private equity firm 💼 - HealthDrive specializes in long-term care services 🏥 🗒️ Here's a summary of the article: - Capital Double Impact recently sold HealthDrive to Cressey & Company, a leading private equity firm. - HealthDrive is a provider of essential long-term care services. - This acquisition has the potential to enhance and expand the availability of quality care for individuals in need. - The deal highlights the growing importance and investment in the long-term care sector. 📝 My thoughts: This acquisition is significant for both Capital Double Impact and Cressey & Company. It reflects their confidence in the long-term care sector and their commitment to improving access to quality care. As American professionals, it's essential to stay informed about developments in the healthcare industry, especially those that impact our future well-being. This acquisition could have far-reaching implications for the availability of long-term care services for ourselves and our loved ones. 🔍 What are your thoughts on the increasing investment in the long-term care sector? How do you see it affecting your future? Let's discuss in the comments! #HealthcareInvestments #LongTermCareServices #FutureCare https://lnkd.in/e-t2fQg7

"What Private Wants and What #HealthInnovation Ventures Must Show." FINN Chair Global Health and Purpose Gil Bashe presents at HITLAB. Gil underscores why too many people are focused on PE money ups and downs instead of where the money is focused and why. He taps into the Galen Growth | Insights You Can Trust data. It's the navigational guide for business development and venture capital. WATCH: https://lnkd.in/guhUBqXf

Up next at #InnovationDublin24 is the “Syndication strategies among European VCs” Panel Session,” moderated by David Cassak of MedTech Strategist: • Evan Castiglia, Partner, Thuja Capital • Jeanne Bolger, Venture Partner, Seroba. • Janke Dittmer, Partner, Gilde Healthcare Key takeaways: • Syndication strategies among European VCs: Like a marathon, raising money requires time and energy, and different investors have the skill sets to help companies at different phases. So there is a tactical and strategic element to syndication. • When choosing syndication partners, the culture of a fund plays a role. How do they react when the company misses a milestone?  Remain informed on new articles, conference updates and more with our helpful medtech community newsletter. Subscribe here: https://bit.ly/42KHJKI

Funding and deal count in Q2 2023 declined, reaching $3.4 billion across 348 deals, but mega-rounds worth $100 million+ increased in deal number and funding amount. Read for insights on M&A activity, IPOs, and #DigitalHealth and #LifeSciences funding.

Read the MedTech Strategies LLC article below about our most recent event on healthcare's current (and future) financing trends. Don't miss Gabriele Brambilla's suggestions for the new year: 1) Watch for microeconomic trends to see what might affect your pathway. 2) Be creative and use different channels to develop relationships and adjust your approach. 3) Focus on clinical evidence and patient impact that might come through a clinical pathway other than 510k. 4) And of course, never give up!

📈 Latest Trends: In the ever-evolving landscape of healthcare, staying ahead is crucial. NL Capital Ventures is at the forefront, embracing trends that redefine the industry. 🚀 Focus Areas: Our commitment extends to three key pillars – medical staffing, home health care, and assisted living. Explore how NL Capital Ventures is innovating within these sectors. 📊 Valuable Statistics: Did you know? The healthcare industry experiences an annual M&A growth of 16%, showcasing the dynamic nature of our field. This insight sheds light on the pressing needs NL Capital Ventures addresses. 💡 Innovation Spotlight: Dive into the cutting-edge solutions NL Capital Ventures employs to overcome challenges. Our data-driven mergers and acquisitions strategy has eliminated industry challenges, fostering extreme efficiency, reduced costs, and increased productivity. This strategic approach reflects our dedication to pioneering advancements that elevate healthcare standards. #HealthcareInnovation #NLcapitalventures #FutureOfHealthcare #IndustryInsights